Folate receptor-α (FOLR1) expression and function in triple negative tumors
Necela, Brian M, Crozier, Jennifer A, Andorfer, Cathy A, Lewis-Tuffin, Laura, Kachergus, Jennifer M, Geiger, Xochiquetzal J, Kalari, Krishna R, Serie, Daniel J, Sun, Zhifu, Moreno-Aspitia, Alvaro, Aspita, Alvaro Moreno, O'Shannessy, Daniel J, Maltzman, Julia D, McCullough, Ann E, Pockaj, Barbara A, Cunliffe, Heather E, Ballman, Karla V, Thompson, E Aubrey, Perez, Edith A
Published in PloS one (27.03.2015)
Published in PloS one (27.03.2015)
Get full text
Journal Article
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis
Mesa, Ruben A, Kiladjian, Jean-Jacques, Catalano, John V, Devos, Timothy, Egyed, Miklos, Hellmann, Andrzei, McLornan, Donal, Shimoda, Kazuya, Winton, Elliott F, Deng, Wei, Dubowy, Ronald L, Maltzman, Julia D, Cervantes, Francisco, Gotlib, Jason
Published in Journal of clinical oncology (01.12.2017)
Published in Journal of clinical oncology (01.12.2017)
Get full text
Journal Article
Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors
Necela, Brian M, Crozier, Jennifer A, Andorfer, Cathy A, Lewis-Tuffin, Laura, Kachergus, Jennifer M, Geiger, Xochiquetzal J, Kalari, Krishna R, Serie, Daniel J, Sun, Zhifu, Moreno-Aspitia, Alvaro, O'Shannessy, Daniel J, Maltzman, Julia D, McCullough, Ann E, Pockaj, Barbara A, Cunliffe, Heather E, Ballman, Karla V, Thompson, E Aubrey, Perez, Edith A
Published in PloS one (30.04.2015)
Published in PloS one (30.04.2015)
Get full text
Journal Article
Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma
Hassan, Raffit, Kindler, Hedy L, Jahan, Thierry, Bazhenova, Lyudmila, Reck, Martin, Thomas, Anish, Pastan, Ira, Parno, Jeff, O'Shannessy, Daniel J, Fatato, Penny, Maltzman, Julia D, Wallin, Bruce A
Published in Clinical cancer research (01.12.2014)
Published in Clinical cancer research (01.12.2014)
Get full text
Journal Article
Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study
Shah, Manish A., Starodub, Alexander, Sharma, Sunil, Berlin, Jordan, Patel, Manish, Wainberg, Zev A., Chaves, Jorge, Gordon, Michael, Windsor, Kevin, Brachmann, Carrie Baker, Huang, Xi, Vosganian, Greg, Maltzman, Julia D., Smith, Victoria, Silverman, Jeffrey A., Lenz, Heinz-Josef, Bendell, Johanna C.
Published in Clinical cancer research (15.08.2018)
Published in Clinical cancer research (15.08.2018)
Get full text
Journal Article
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial
Harrison, Claire N, Vannucchi, Alessandro M, Platzbecker, Uwe, Cervantes, Francisco, Gupta, Vikas, Lavie, David, Passamonti, Francesco, Winton, Elliott F, Dong, Hua, Kawashima, Jun, Maltzman, Julia D, Kiladjian, Jean-Jacques, Verstovsek, Srdan
Published in The Lancet. Haematology (01.02.2018)
Published in The Lancet. Haematology (01.02.2018)
Get more information
Journal Article
A phase 2 study of simtuzumab in patients with primary, post‐polycythaemia vera or post‐essential thrombocythaemia myelofibrosis
Verstovsek, Srdan, Savona, Michael R., Mesa, Ruben A., Dong, Hua, Maltzman, Julia D., Sharma, Shringi, Silverman, Jeffrey, Oh, Stephen T., Gotlib, Jason
Published in British journal of haematology (01.03.2017)
Published in British journal of haematology (01.03.2017)
Get full text
Journal Article
A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia
Verstovsek, Srdan, Courby, Stephane, Griesshammer, Martin, Mesa, Ruben A, Brachmann, Carrie Baker, Kawashima, Jun, Maltzman, Julia D, Shao, Lixin, Xin, Yan, Huang, Daniel, Bajel, Ashish
Published in Leukemia research (01.09.2017)
Published in Leukemia research (01.09.2017)
Get full text
Journal Article
Population pharmacokinetics and exposure–response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection
Gupta, Anubha, Hussein, Ziad, Hassan, Raffit, Wustner, Jason, Maltzman, Julia D., Wallin, Bruce A.
Published in Cancer chemotherapy and pharmacology (01.04.2016)
Published in Cancer chemotherapy and pharmacology (01.04.2016)
Get full text
Journal Article
Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed
Christoph, Daniel C., Asuncion, Bernadette Reyna, Hassan, Biftu, Tran, Cindy, Maltzman, Julia D., O’Shannessy, Daniel J., Wynes, Murry W., Gauler, Thomas C., Wohlschlaeger, Jeremias, Hoiczyk, Mathias, Schuler, Martin, Eberhardt, Wilfried E., Hirsch, Fred R.
Published in Journal of thoracic oncology (01.01.2013)
Published in Journal of thoracic oncology (01.01.2013)
Get full text
Journal Article
Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer Patients
Christoph, Daniel C, Reyna-Asuncion, Bernadette, Hassan, Biftu, Tran, Cindy, Maltzman, Julia D, O'Shannessy, Daniel J, Gauler, Thomas C, Wohlschlaeger, Jeremias, Schuler, Martin, Eberhardt, Wilfried E, Hirsch, Fred R
Published in Clinical lung cancer (01.09.2014)
Published in Clinical lung cancer (01.09.2014)
Get full text
Journal Article
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of GS-5745 combined with mFOLFOX6 as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma
Bendell, Johanna C., Starodub, Alexander, Huang, Xi, Maltzman, Julia D., Wainberg, Zev A., Shah, Manish A.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of GS-5745 combined with mFOLFOX6 as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma
Bendell, Johanna C., Starodub, Alexander, Huang, Xi, Maltzman, Julia D., Wainberg, Zev A., Shah, Manish A.
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Results of a phase I study of GS-5745 in combination with gemcitabine and nab-paclitaxel in patients (pts) with advanced pancreatic cancer
Bendell, Johanna C., Huang, Xi, Smith, Victoria, Maltzman, Julia D., Starodub, Alexander
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A phase II, open-label, randomized study to evaluate the efficacy and safety of GS-5745 combined with nivolumab versus nivolumab alone in subjects with unresectable or recurrent gastric or gastroesophageal junction adenocarcinoma
Shah, Manish A., Metges, Jean-Philippe, Chun, Patrick Youngwhan, Smith, Victoria, Maltzman, Julia D., Wainberg, Zev A.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Evaluating collagen neoepitopes as pharmacodynamic biomarkers of GS-5745, an MMP9 inhibitor, in advanced gastric cancer
Brachmann, Carrie Baker, Zhang, Yafeng, Zavodovskaya, Marianna, Hu, Jing, Maltzman, Julia D., Smith, Victoria, Xiao, Yuanyuan, Patterson, Scott D
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of GS-5745 combined with mFOLFOX6 as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma
Bendell, Johanna C., Starodub, Alexander, Wainberg, Zev A., Wu, Meihua, Werner, Douglas, Maltzman, Julia D., Shah, Manish A.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Results of a phase I study of GS-5745 in combination with mFOLFOX in patients with advanced unresectable gastric / GE junction tumors
Shah, Manish A., Starodub, Alexander, Wainberg, Zev A., Wu, Meihua, Smith, Victoria, Maltzman, Julia D., Bendell, Johanna C.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Updated results of a phase 1 study combining the matrix metalloproteinase 9 inhibitor GS-5745 with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer
Bendell, Johanna C., Patel, Manish R., Brachmann, Carrie Baker, Huang, Xi, Maltzman, Julia D., Smith, Victoria, Vosganian, Gregory Sumpao, Wainberg, Zev A., Starodub, Alexander
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Updated results of a phase 1 study combining the matrix metalloproteinase 9 inhibitor GS-5745 and mFOLFOX6 in patients with advanced gastric/gastroesophageal junction cancer
Shah, Manish A., Starodub, Alexander, Berlin, Jordan, Brachmann, Carrie Baker, Huang, Xi, Smith, Victoria, Maltzman, Julia D., Wainberg, Zev A., Bendell, Johanna C.
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article